Crossmark

ASO Visual Abstract: MicroRNA-Based Prediction of Posthepatectomy Liver Failure and Mortality Outperforms Established Markers of Preoperative Risk Assessment

Crossref DOI link: https://doi.org/10.1245/s10434-025-17691-1

Published Online: 2025-06-25

Published Print: 2025-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kern, Anna Emilia

Pereyra, David

Santol, Jonas

Ammann, Markus

Kim, Sarang

Huber, Felix Xaver

Weninger, Jeremias

Brunner, Sarah

Laferl, Valerie

Herrmann, Yannic

Jankoschek, Anna

Ortmayr, Gregor

Rumpf, Benedikt

Schuetze, Marcel

Valenta, Rosmarie

Krestan, Christian

Zauner, Guenther

Zechmeister, Melanie

Skalicky, Susanna

Hackl, Matthias

Assinger, Alice

Gruenberger, Thomas

Starlinger, Patrick
License Information

Text and Data Mining valid from 2025-06-25

Version of Record valid from 2025-06-25
More Information

Article History

First Online: 25 June 2025

Disclosures

: Patrick Starlinger was involved in the development of hepatomiR®, the testing system discussed in this article and is a consultant for TAmiRNA GmbH, the company that developed hepatomiR®. Alice Assinger was involved in the development of hepatomiR®. Matthias Hackl is employed by and owns stock in TAmiRNA GmbH. Susanna Skalicky is employed by TAmiRNA GmbH.

Document is current

Any future updates will be listed below